Skip to main content

Drug Interactions between digitoxin and licorice

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

digitoxin licorice

Applies to: digitoxin and licorice

GENERALLY AVOID: Chronic use of licorice may potentiate the risk of digitalis toxicity and other cardiovascular complications in patients treated with cardiac glycosides. Glycyrrhizic acid, a component of licorice, can induce hypokalemia, hypernatremia, edema, hypertension, and suppression of the renin-aldosterone system by virtue of its mineralocorticoid activity. In digitalized patients, electrolyte imbalance such as hypokalemia and hypomagnesemia can lead to arrhythmias, while other chronic effects of glycyrrhizic acid can compromise overall cardiovascular condition. In one case report, an 84-year-old man developed congestive heart failure secondary to digitalis toxicity shortly after he began using a Chinese herbal laxative containing licorice 400 mg and rhubarb 1600 mg three times a day. The patient had mitral regurgitation with atrial fibrillation and had been treated with digoxin and furosemide. He recovered 18 days after stopping both digoxin and the herbal laxative.

MANAGEMENT: Patients should consult a healthcare provider before taking any herbal or alternative medicine. In general, chronic use of licorice and licorice-containing products should be avoided in patients treated with cardiac glycosides.

References (11)
  1. Cumming AM, Boddy K, Brown JJ, et al. (1980) "Severe hypokalaemia with paralysis induced by small doses of liquorice." Postgrad Med J, 56, p. 526-9
  2. Cumming A (1976) "Severe reduction of serum potassium induced by licorice." Nurs Times, 72, p. 367-70
  3. Harada T, Ohtaki E, Misu K, Sumiyoshi T, Hosoda S (2002) "Congestive heart failure caused by digitalis toxicity in an elderly man taking a licorice-containing chinese herbal laxative." Cardiology, 98, p. 218
  4. de Klerk GJ, Nieuwenhuis MG, Beutler JJ (1997) "Lesson of the week: hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum." BMJ, 314, p. 731
  5. Edwards CR (1991) "Lessons from licorice." N Engl J Med, 325, p. 1242-3
  6. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR (1987) "Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age." Lancet, 2, p. 821-4
  7. Nielsen I, Pedersen RS (1984) "Life-threatening hypokalaemia caused by liquorice ingestion." Lancet, 1, p. 1305
  8. Rosseel M, Schoors D (1993) "Chewing gum and hypokalaemia." Lancet, 341, p. 175
  9. Clyburn EB, DiPette DJ (1995) "Hypertension induced by drugs and other substances." Semin Nephrol, 15, p. 72-86
  10. Farese RV, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R (1991) "Licorice-induced hypermineralocorticoidism." N Engl J Med, 325, p. 1223-7
  11. Elinav E, Chajek-Shaul T (2003) "Licorice consumption causing severe hypokalemic paralysis." Mayo Clin Proc, 78, p. 767-8

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.